Biomarker and Diagnostics Strategy

This is where precision medicine starts – whether you’re trying to find the right tools to uncover new biomarkers, identify CDx partners, launch an IVD, or understand how your assay will fit into the clinical journey, DeciBio has you covered. Nobody knows biomarkers and CDx better than DeciBio.

Our Experts

Stephane Budel

Founding Partner

David Cavanaugh

Founding Partner

Andrew Aijian

Colin Enderlein

Schedule a Call

Related Client Results

All Client Results

Clinical Diagnostics

Genetic Testing Company Assessment

A group asked DeciBio to identify and evaluate clinical genetic testing labs for potential acquisition

Target Identification

Pre-due diligence research on a potential acquisition target

A multi-billion dollar life science company needed pre diligence on a potential acquisition target

Competitive Analysis

Pharma & Biotech

Clinical, Genomic, and Pathology Real-World Data (RWD) Market Landscape Assessment

A real-world data (RWD) provider wanted to identify key use cases, unmet needs, and future opportunities in the RWD market, with a particular focus on clinical, genomic, and pathology RWD and biopharma users.

Voice-of-Customer Research

Pricing Strategy

Competitive Analysis

Pharma & Biotech

Healthcare IT Solution Market Opportunity

A leading pharmaceutical & clinical diagnostics manufacturer wanted to understand the market opportunity for a novel multidisciplinary cancer conference IT support solution

Voice-of-Customer Research

Go-to-Market Strategy

Competitive Analysis

Clinical Diagnostics

Carrier Screening Landscape Assessment

A leading diagnostics player wanted an assessment of the current and future carrier screening landscape, primarily in the U.S., to guide their product development strategy

Voice-of-Customer Research

Methylation Analysis Opportunity Identification for Ultra-Sensitive Detection Platform

A leader in research tools and clinical diagnostic development asked us to evaluate the opportunity for an ultrasensitive detection platform in methylation analysis

Target Identification

Precision Medicine is evolving at a rapid pace

Discover how we can help